Literature DB >> 18810674

Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - do not miss vaccination before starting therapy.

J Hadem1, M Cornberg, C Hauptmann, U Süttmann, M P Manns, H Wedemeyer.   

Abstract

We report on a 35-year-old man who developed pneumococcal meningitis while receiving antiviral therapy with interferon (consensus interferon, CIFN) and ribavirin for chronic hepatitis C. Antibiotic therapy was started four days after the onset of symptoms. Unfortunately, the patient developed a persisting right-sided cochlear hearing impairment. Antiviral therapy led to sustained viral response of hepatitis C. At the age of 14 years he had experienced a hemorrhagic shock after a traffic accident, received multiple blood transfusions and undergone a splenectomy. He had not received vaccination against Streptococcus pneumoniae. This case report reminds us that splenectomized patients without previous pneumococcal vaccination should receive such vaccination before immunomodulatory treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18810674     DOI: 10.1055/s-2008-1027149

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  1 in total

1.  Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin.

Authors:  Tae-Hee Lee; Kee-Ook Lee; Yong-Seok Kim; Sun-Moon Kim; Kyu-Chan Huh; Young-Woo Choi; Young-Woo Kang
Journal:  Korean J Intern Med       Date:  2014-04-29       Impact factor: 2.884

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.